Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
The following is a round-up of earnings for London-listed companies, issued on Wednesday and Tuesday and not separate ...
GENinCode PLC 25 September 2024 25 September 2024 GENinCode Plc ("GENinCode", the "Company" or the "Group") Interim report First US...
GENinCode PLC on Friday announced its collaboration with The Family Heart Foundation, the University of Texas Southwe ...
GENinCode PLC 20 September 2024 GENinCode Plc ("GENinCode" or the "Company") DISCOVER FH collaboration with Family Heart Foundation®, UT...
GENinCode PLC 09 September 2024 9 September 2024 GENinCode Plc ("GENinCode" or the "Company") Notice of results Analyst and investor...
GENinCode PLC 28 August 2024 GENinCode Plc ("GENinCode" or the "Company") CARDIO inCode-Score® presentation on polygenic risk of Coronary...
GENinCode PLC 27 June 2024 GENinCode Plc ("GENinCode" or the "Company") Result of AGM Oxford, UK. GENinCode Plc (AIM: GENI), the...
GENinCode PLC 05 June 2024 GENinCode Plc ("GENinCode" or the "Company") Posting of Annual Report and Notice of Annual General Meeting ...
GENinCode PLC on Monday reported improved financial performance in 2023 as the company scaled up operations. The Oxf ...
GENinCode PLC 03 June 2024 GENinCode Plc ("GENinCode" or the "Company") Final results Oxford, UK. GENinCode Plc (AIM: GENI), the...
GENinCode PLC 23 May 2024 GENinCode Plc ("GENinCode" or the "Company") Notice of results Analyst and investor briefing Oxford, UK...
GENinCode PLC 01 May 2024 GENinCode Plc ("GENinCode" or the "Company") CARDIO inCode-Score® presentation at European Society of Cardiology...
GENinCode PLC 26 April 2024 26 April 2024 GENinCode Plc ("GENinCode" or the "Company") Grant of Share Options, Surrender of Existing...
GENinCode PLC 04 April 2024 GENinCode Plc ("GENinCode" or the "Company") CARDIO inCode-Score® clinical publication on polygenic risk of...
GENinCode PLC on Thursday said its risk of ovarian cancer risk test has been recommended as preferred test in England ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관